News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article first appeared on GuruFocus. Release Date: August 04, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Record second quarter sales of $9.5 billion, up 9% year-over-year, driven by strong global power …
Sharemaestro market context Trend signal active 52 weeks +80.6% · Next-week setup negative 17.0%Marcus & Millichap has successfully arranged the sale of a two-property, 36-unit multifamily portfolio in Vineland, New Jersey, for $5,525,000. The portfolio, which comprises townhome-style and bungalow-style buildings, attracted significant regional interest with 46 groups signing confidentiality agreements. This transaction highlights the growing appeal …
Marcus & Millichap announced the sale of Garden Villas Apartments, a 73-unit multifamily property in Oakland, California, for $9.75 million, alongside arranging $7.3125 million in acquisition financing. The transaction highlighted the continued investor interest in affordable housing with long-term preservation opportunities and involved extensive …
Cummins reported record Q2 2026 revenue of $9.5 billion, beating analyst estimates, and raised its full-year outlook. However, EPS of $6.73 missed expectations, causing shares to fall by 5.76% in premarket trading. The company saw strong demand in power generation, especially from data centers, …
Marcus & Millichap has brokered the $8.3 million sale of West Pembroke Square, a 30,250-square-foot retail property in Pembroke Pines, Florida. The retail center, built in 1987, features 19 retail suites and was purchased by Jorge Gonzalez. Matt Albregts represented the seller, while Jonathan …
Cummins Inc. reported record Q2 2026 revenue of $9.5 billion, a 9% year-over-year increase, driven by surging data center demand and a strong China market. The company raised its full-year revenue growth outlook to 10%-13% and EBITDA margin to 18%-18.5%. A new multi-year agreement …
Institutional Property Advisors (IPA), a division of Marcus & Millichap, brokered the $90.5 million sale of the 400-unit Ponte Verde at Palm Beach Lakes condominium in West Palm Beach, Florida, to New Jersey-based Kamson Corp. This transaction represents one of Florida's largest condominium-to-multifamily rental …
Marcus & Millichap’s Institutional Property Advisors (IPA) division has brokered the $90.5 million sale of the 400-unit Ponte Verde at Palm Beach Lakes condominium in West Palm Beach, Florida, to Kamson Corp. This transaction represents one of Florida's largest condominium-to-multifamily rental conversions, driven by …
Immix Biopharma (Nasdaq: IMMX) announced its participation in the Morgan Stanley 24th Annual Global Healthcare Conference from September 14-16, 2026, where it will host one-on-one investor meetings. The company will discuss its lead AL Amyloidosis CAR-T candidate, NXC-201, which has received FDA Breakthrough Therapy, …
Cummins (CMI) reported $9.46 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 9.4%. EPS of $6.94 for the same period compares to $6.43 a year ago. The reported revenue represents a surprise of +1.38% over the Zacks Consensus …
Sharemaestro market context Trend signal active 52 weeks +80.6% · Next-week setup negative 17.0%Immix Biopharma (IMMX) announced its participation in the Morgan Stanley 24th Annual Global Healthcare Conference from September 14-16, 2026, where it will host meetings with institutional investors. The company, a leader in treating relapsed/refractory AL Amyloidosis, will discuss its lead CAR-T cell therapy, NXC-201, …
Investing.com -- Cummins Inc (NYSE:CMI) reported second-quarter results that missed earnings expectations despite beating revenue estimates, as higher incentive compensation weighed on profitability. The company posted adjusted earnings per share of $6.73, falling short of the analyst consensus of $7.26. Revenue reached a record …
Sharemaestro market context Trend signal active 52 weeks +80.6% · Next-week setup negative 17.0%Cummins Inc. announced its financial results for the second quarter and first half of 2026. For the second quarter, sales increased to $9,457 million from $8,643 million, with net income rising to $932 million. For the six months, sales reached $17,855 million, though net …
Sharemaestro market context Trend signal active 52 weeks +58.6% · Next-week setup positive 57.5%(RTTNews) - Cummins Inc. (CMI) will host a conference call at 10:00 AM ET on August 4, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investor.cummins.com/events-presentations The views and opinions expressed herein are the views and opinions …
Sharemaestro market context Trend signal active 52 weeks +80.6% · Next-week setup negative 17.0%Cummins (CMI) came out with quarterly earnings of $6.94 per share, missing the Zacks Consensus Estimate of $7.33 per share. This compares to earnings of $6.43 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …
Sharemaestro market context Trend signal active 52 weeks +80.6% · Next-week setup negative 17.0%Cummins (NYSE:CMI) Posts Better-Than-Expected Sales In Q2 CY2026 But Stock Drops Engine manufacturer Cummins (NYSE:CMI) announced better-than-expected revenue in Q2 CY2026, with sales up 9.4% year on year to $9.46 billion. Its GAAP profit of $6.73 per share was 6.1% below analysts' consensus estimates. …
Sharemaestro market context Trend signal active 52 weeks +80.6% · Next-week setup negative 17.0%Cummins (CMI.N) reported weaker-than-expected second-quarter profit despite robust demand for power generators, particularly from AI-driven data centers, and an improving North American truck market. The company's shares fell in premarket trading. Cummins raised its full-year 2026 revenue forecast to 10-13% growth and saw strong …
Cummins Inc. reported increased Q2 earnings and net sales, leading the company to raise its revenue growth outlook for 2026. This positive financial performance comes despite the company missing quarterly profit estimates, primarily due to strong demand in its generator segment.
Cummins Inc. reported record second-quarter 2026 net sales of $9.457 billion, a 9% increase year-over-year, driven by strong demand in data center power generation and North American truck markets. The company raised its full-year 2026 revenue guidance to 10%-13% growth and an EBITDA margin …
(RTTNews) - Cummins Inc. (CMI) revealed earnings for its second quarter that Increased, from the same period last year The company's earnings came in at $932 million, or $6.73 per share. This compares with $890 million, or $6.43 per share, last year. The company's …
Sharemaestro market context Trend signal active 52 weeks +80.6% · Next-week setup negative 17.0%Record second-quarter revenues of $9.5 billion; GAAP1 Net Income of $932 million, or 9.9% of sales EBITDA2 in the second quarter was 17.5% of sales; Diluted EPS of $6.73 Full-year revenues are expected to range from up 10% to up 13%, an improvement from …
Sharemaestro market context Trend signal active 52 weeks +80.6% · Next-week setup negative 17.0%Janus Henderson Group PLC significantly reduced its stake in Cummins Inc. by 56.2% in the first quarter, selling 46,123 shares but still retaining 35,910 shares valued at approximately $19.3 million. Despite this, institutional investors collectively hold 83.46% of Cummins, which recently surpassed quarterly earnings …
Edgestream Partners L.P. significantly reduced its stake in Cummins Inc. by 81.7% in the first quarter, selling 8,841 shares and retaining 1,978 shares valued at $1.06 million. Despite this, institutional investors own a substantial 83.46% of the company, and analysts maintain a "Moderate Buy" …
Summit Therapeutics Inc. (SMMT) presents a compelling opportunity in the biotechnology sector, with analysts projecting a potential upside of 117.69% based on an average target price of $28.34. The company, focused on innovative biopharmaceuticals like ivonescimab for cancer treatment, is currently in phase III …
Search by ticker symbol or company name and select a result to open its chart.